Ezequiel M. Mauro - Publications

Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statement.

Journal: Nature reviews. Clinical oncology

Published: May 06, 2026

Liver support systems for adults with acute liver failure.

Journal: The Cochrane database of systematic reviews

Published: April 28, 2026

Reply to: "Beyond binary classification of non-proportional hazards: Methodological considerations for interpreting pivotal HCC trials".

Journal: Journal of hepatology

Published: April 16, 2026

The Liver Frailty Index improves mortality risk prediction for GEMA-Na.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: March 03, 2026

Chronic liver disease is associated with earlier-stage cholangiocarcinoma diagnosis and improved prognosis: Findings from the GLOBAL-BTC registry.

Journal: Journal of hepatology

Published: February 06, 2026

Hepatitis C virus microelimination program in hemodialysis patients: success of a multi-stakeholder partnership based on a national eradication strategy.

Journal: Medicina

Published: November 28, 2025

Endocrine Dysfunction in Cirrhosis: From Testosterone to Adrenal Precursors, Bridging Frailty and Prognosis.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: October 31, 2025

Frailty in early HCC transplant candidates: It's not only about the tumor.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: October 22, 2025

ESMO-MCBS v2.0: Advances, challenges, and perspectives in the assessment of clinical benefit in oncology.

Journal: JHEP reports : innovation in hepatology

Published: July 09, 2025

Hepatocellular carcinoma: Epidemiology, diagnosis and treatment.

Journal: JHEP reports : innovation in hepatology

Published: June 12, 2025

Artificial intelligence predicts outcome-related molecular profiles and vascular invasion in hepatocellular carcinoma.

Journal: JHEP reports : innovation in hepatology

Published: June 06, 2025

Strategies to address non-proportional hazards between survival curves - Lessons from phase III trials in hepatocellular carcinoma.

Journal: Journal of hepatology

Published: January 31, 2025